Pyrimidinone compounds as human neutrophil elastase inhibitors
US9365577B2 · kind B2 · utility
0Cited by
0References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 17, 2013 |
| Grant date | Jun 14, 2016 |
| Priority date | — |
| Expiry date | Dec 17, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D519/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Pyrimidinone compounds defined herein exhibit human neutrophil elastase inhibitory properties and are useful for treating diseases and conditions in which HINE is implicated.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.